Thermo Fisher to sell three analytical divisions to GE Healthcare


Thermo Fisher Scientific has agreed to sell three of its analytical technology divisions to GE Healthcare for just over $1 billion (£645 million). The move is intended to satisfy the demands of US competition regulators and speed up final approval for Thermo’s ongoing takeover of Life Technologies.

GE will take over Thermo’s cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013.


Related Content

Business roundup

28 October 2009 Business

news image

Industry news, November 2009

Thermo Fisher to buy Life Technologies in $15.8bn deal

19 April 2013 Business

news image

Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets

Most Commented

Crawling chemical system acts as if it’s alive

24 May 2016 Research

news image

Intriguing globule that moves, eats and defecates

Let's see that again

27 May 2016 In the Pipeline

news image

Has chemistry evaded the reproducibility crises affecting other branches of science? Or is it just a question of scale, asks ...